biotech
biotech Articles
Proteon Therapeutics shares were absolutely crushed on Thursday after the firm announced results from its late-stage trial in patients with chronic kidney disease.
Published:
Last Updated:
Axsome shares jumped on Wednesday after the firm gave an update from the FDA regarding its AXS-05 for the treatment of major depressive disorder.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
Curis shares jumped when the firm announced that it entered into an agreement to sell rights to a portion of royalty revenues on worldwide net sales of Erivedge.
Published:
Last Updated:
Biogen shares made a slight gain early on Monday after the firm made an SEC filing indicating that it will be buying back a sizable amount of stock.
Published:
Last Updated:
Neurotrope Inc. (NASDAQ: NTRP) may be a winner by default in the battle against Alzheimer’s disease after shares of Biogen Inc. (NASDAQ: BIIB) suffered handily with the announcement that it and...
Published:
Last Updated:
Biogen shares were crushed in Thursday’s session after the firm announced that it would be discontinuing its late-stage trial for Alzheimer’s disease.
Published:
Last Updated:
Gene therapy may become the next frontier for drug companies seeking to make billions of dollars improving or even curing certain diseases.
Published:
Last Updated:
Altimmune shares surged on Tuesday following results from its midstage study of a intranasal influenza vaccine candidate.
Published:
Last Updated:
Dermira shares more than doubled on Monday after the firm announced midstage results from its Eczema study.
Published:
Last Updated:
PhaseBio shares more than doubled on Monday after the firm released results from an early-stage clinical trial of its antiplatelet reversal agent.
Published:
Last Updated:
We screened our 24/7 Wall St. research database and found five biotech stocks trading under the $10 level that could provide investors with some solid upside potential.
Published:
Last Updated:
Karyopharm shares jumped on Friday after the firm announced an FDA update from the FDA on its treatment for myeloma.
Published:
Last Updated:
In a new research report, RBC did some intense digging in the small-cap arena and came up with some fascinating research. These are five top small-cap growth plays suited for aggressive accounts.
Published:
Last Updated:
Patients suffering anemia due to chronic kidney disease are sure to be content with new positive top-line results from two Phase 3 active-controlled pivotal studies.
Published:
Last Updated: